期刊文献+

全身热化疗治疗晚期癌症15例临床观察 被引量:2

Clinical Analysis of Treatment of 15 Cases of Advanced Malignant Tumor with Whole Body Thermo-chemotherapy
下载PDF
导出
摘要 目的探讨全身热化疗对晚期肿瘤的疗效及安全性。方法15例晚期恶性肿瘤患者在全麻状态下用TEMET 1000型体外循环全身热疗灌注治疗系统,进行全身加温治疗,平台期治疗温度达42-42.5℃,同时静脉滴注顺铂或(和)5-FU化疗。通过临床观察及随访追踪,初步评估疗效。结果明显止痛84.6%(11/13),抑制肿瘤有效率为56.7%(PR+SD),半年及1年病灶稳定率为66.7%(8/12)、41.7%(5/12),6个月、1年、1年6个月生存率分别为85.7%(12/14)、72.7%(8/11)、60.0%(6/10),部分患者甚至能达到消灭肿瘤的效果。结论全身热化疗对晚期肿瘤是一种安全有效的治疗方法,将为晚期恶性肿瘤病人的治疗带来新的希望。 Objective Study effect and reliability of the whole body thermo-chemotherapy (WBTCT) for advanced malignant tumor. Methods Use TEMET 1000 to treat 15 patients with advanced malignant tumor under general anesthesia. All patients had been treated by Thermo-therapy to whole body, and injection of DDP/5-FU during the stable period with body temperature 42-42.5℃. Evaluate the effect by clinical observ ation and by follow-up. Results The curative effects are 84.6% (11/13) relieving pain, 56.7% inhibition tumor cell (PR+SD), 66.7% stationary phase of rumors in half year and 41.7% in one year. The 6 months, 1 year, 1 year and 6 months survival rate are 85.7%(12/14), 72.7%(8/ll), 60.0%(6/10), respectively, and especially, one part of the patients' tumors were extinction. Conclusion WBTCT is a safe and effective method and will bring a new hope for the advanced malignant tumor patients.
出处 《深圳中西医结合杂志》 2005年第3期159-161,共3页 Shenzhen Journal of Integrated Traditional Chinese and Western Medicine
关键词 全身热疗 体外循环 肿瘤化疗 Whole body hyperthermia Extracorporeal circulation Tumor chemotherapy
  • 相关文献

参考文献4

  • 1詹宏杰,梁寒.肿瘤热疗的研究[J].国际肿瘤学杂志,2005,32(1):35-38. 被引量:53
  • 2陈杰,陶惠民.全身热疗在肿瘤治疗中的应用机制[J].国外医学(骨科学分册),2003,24(3):157-159. 被引量:5
  • 3张莉 曹永清 肖劲军.体外高频透热综合治疗晚期恶性肿瘤73例近期疗效观察[C]..第26届国际肿瘤热疗大会论文集[C].,2004.60.
  • 4Schulte JH, Schramm A, Pressel T, et al. Microarray-analysis:a new approach to study the molecular mechanisms of thermochemotherapy [J]. Klin Padiatr, 2003, 215(6):298-302

二级参考文献23

  • 1梁寒,李景武,史玉荣,牛瑞芳,王仆,郝希山.热疗对人类结肠癌细胞株细胞黏附因子表达的影响[J].中华医学杂志,2004,84(15):1299-1303. 被引量:18
  • 2Steinhausen D, Mayer WK, Ardenne MV. Strahlenther Onkol,1994,170(6) :322~334.
  • 3Kerner T, Deja M, Ahlers O, et al. Intensive Care Med,1999,25(9):959~965.
  • 4Ostberg JR, Repasky EA. Immunol Invest, 2000,29 (2):139-142.
  • 5Tomasovic SP, Vasey TA, Story MD, et al. Int J Hyperthermia,1994,10(2) :247~262.
  • 6Sakaguchi Y, Stephens LC, Makino M, et al. Cancer Res, 1995,55(22) :5459~5464.
  • 7Hildebrandt B, Wust P, Ahlero O, et al. Crit Rev Oncol Hematol, 2002,43(1) :33~65.
  • 8Gorcyca W, Gong J, Ardelt B, et al. Cancer Res, 1993;53(13);3186~3192.
  • 9Robin HI, Kutz M, Wiedemann GJ, et al. Cancer Lett, 1995,97(2):195~ 201.
  • 10Katschinski DM, Wiedemann GJ, Longo W. et al. Cytokine Growth Factor Rev, 1999,10 (2):93 ~ 97.

共引文献56

同被引文献5

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部